BioNTech SE (BNTX) Total Debt (2018 - 2025)

BioNTech SE (BNTX) has 8 years of Total Debt data on file, last reported at $409.4 million in Q4 2025.

• In Q4 2025, Total Debt fell 74.29% year-over-year to $409.4 million; the TTM figure through Dec 2025 stood at $409.4 million (down 74.29% YoY), while the FY2025 annual figure was $397.4 million, down 75.05% from the prior year.
• Total Debt eased to $409.4 million in Q4 2025, from $698.4 million in the prior quarter.
• Across five years, Total Debt topped out at $11.1 billion in Q2 2022 and bottomed at $37.3 million in Q3 2022.
• A 5-year average of $1.2 billion and a median of $437.9 million in 2025 frame the typical range for Total Debt.
• The widest YoY moves for Total Debt: up 838.43% in 2023, down 98.3% in 2023.
• Year by year, Total Debt stood at $1.6 billion in 2021, then plunged by 48.42% to $807.2 million in 2022, then tumbled by 39.49% to $488.5 million in 2023, then soared by 226.02% to $1.6 billion in 2024, then slumped by 74.29% to $409.4 million in 2025.
• The last three Total Debt figures came in at $409.4 million (Q4 2025), $698.4 million (Q3 2025), and $164.1 million (Q2 2025), per Business Quant data.

Peer Comparison